 Epidermolysis Bullosa
"Epidermolysis Bullosa" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.
| Descriptor ID |
D004820
|
| MeSH Number(s) |
C16.131.831.493 C16.320.850.275 C17.800.804.493 C17.800.827.275 C17.800.865.410
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Epidermolysis Bullosa".
Below are MeSH descriptors whose meaning is more specific than "Epidermolysis Bullosa".
This graph shows the total number of publications written about "Epidermolysis Bullosa" by people in this website by year, and whether "Epidermolysis Bullosa" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 0 | 2 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 1 | 3 | | 2012 | 1 | 0 | 1 | | 2013 | 2 | 0 | 2 | | 2014 | 4 | 0 | 4 | | 2017 | 0 | 1 | 1 | | 2018 | 2 | 0 | 2 | | 2019 | 1 | 0 | 1 | | 2020 | 7 | 0 | 7 | | 2021 | 5 | 0 | 5 | | 2022 | 6 | 0 | 6 | | 2023 | 3 | 0 | 3 | | 2024 | 3 | 0 | 3 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Epidermolysis Bullosa" by people in Profiles.
-
Murrell DF, Bodemer C, Bruckner AL, Cunningham T, Davis C, Fern?ndez MF, Kiritsi D, Maher L, Sprecher E, Torres-Pradilla M, Kern JS. Long-term safety and efficacy of Oleogel-S10 (birch bark extract) in epidermolysis bullosa: 24-month results from the phase III EASE study. Br J Dermatol. 2025 May 19; 192(6):1007-1017.
-
Perez VA, Mulinda C, Bruckner AL, Diaz LZ, Hook KP, Lara-Corrales I, Levy ML, Price HN, Morel KD, Levin LE. Transition of care in adolescents with epidermolysis bullosa: The provider perspective. Pediatr Dermatol. 2024 Nov-Dec; 41(6):1117-1120.
-
Feinstein JA. Learning to Say Goodbye. N Engl J Med. 2024 May 16; 390(19):1742-1743.
-
Abreu Molnar B, Levin L, Yun D, Morel K, Wiss K, Wieser J, Ward C, Trice H, Garcia-Romero MT, Stephenson A, Provost A, Price HN, Perman MJ, Moxon M, Moeves B, McCuaig CC, McCarthy C, Lucky AW, Levy ML, Lee M, Lara-Corrales I, Henner N, Halliburton N, Griffith E, Gorell E, Glick S, Eichenfield L, Collins C, Bruckner AL, Boulrice B, Bayliss S, Badger K, Paller AS. Inpatient management of epidermolysis bullosa: Consensus-based hands-on instructions for neonates and postneonates. J Am Acad Dermatol. 2024 Aug; 91(2):290-299.
-
Scollan ME, Levin LE, Lucky AW, Hook KP, Peoples K, Bruckner AL, Feinstein JA, Pope E, McCuaig CC, Powell J, Eichenfield LF, Levy ML, Diaz L, Glick SA, Paller AS, Browning JC, Morel KD. Characterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa. Pediatr Dermatol. 2023 Sep-Oct; 40(5):863-865.
-
Liy-Wong C, Tarango C, Pope E, Coates T, Bruckner AL, Feinstein JA, Schwieger-Briel A, Hubbard LD, Jane C, Torres-Pradilla M, Zmazek M, Lara-Corrales I. Consensus guidelines for diagnosis and management of anemia in epidermolysis bullosa. Orphanet J Rare Dis. 2023 02 23; 18(1):38.
-
Kern JS, Sprecher E, Fernandez MF, Schauer F, Bodemer C, Cunningham T, L?we S, Davis C, Sumeray M, Bruckner AL, Murrell DF. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study. Br J Dermatol. 2023 01 23; 188(1):12-21.
-
Rangu S, Collins J, Garc?a-Romero MT, Augsburger BD, Bruckner AL, Diaz LZ, Eichenfield LF, Faig W, Gorell ES, Lefferdink R, Lucky AW, Morel KD, Paller AS, Park H, Pastrana-Arellano E, Peoples K, Wiss K, Perman MJ, Castelo-Soccio L. Assessing pain catastrophizing and functional disability in pediatric epidermolysis bullosa patients. Pediatr Dermatol. 2023 May-Jun; 40(3):422-427.
-
Feinstein JA, Bruckner AL, Chastek B, Anderson A, Roman J. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa. Orphanet J Rare Dis. 2022 09 29; 17(1):367.
-
Betancourt NJ, Sum K, Gorell ES, Tang JY, Chiou AS. Asymptomatic, microscopic hematuria in epidermolysis bullosa: A single center retrospective case series. J Am Acad Dermatol. 2022 12; 87(6):1419-1421.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|